Excerpt from that article on BMSN...
"The press release didn't cite any specific dollar amounts, but it did mention VIBRAGENE anticipates needing about 100,000 specimens processed over the next twelve months.
Though we don't want to get too presumptuous, processing comparable gene tests can cost anywhere from as low as $30 to as much as a few hundred bucks, depending on what needs to be identified.
Just for perspective and scope, let's say each test will generate $50 for Bio-Matrix. At 100,000 pieces per year, that turns into revenues of $5 million. Point being, no matter what the average price is, it could be significant sales for the company."